GeneDx Decentralizes Genetic Testing with Fabric Genomics' AI Interpretation Platform!

GeneDx (WGS) provides a variety of genetic tests to identify and treat rare and hereditary diseases earlier. The highly profitable exome/genome sequencing, which doubled revenue in the latest fourth quarter, is already responsible for 38% of the revenue mix. A database containing 750,000 genomes and exomes for translating tests into clinical outcomes offers competitive advantages. In the US, 1 in 10 people is affected, half of whom are children. On average, it takes 16 different tests and five years to arrive at the correct diagnosis. Tests like...